Pedrazzani Corrado, Bernini Marco, Giacopuzzi Simone, Pugliese Raffaele, Catalano Filippo, Festini Mara, Rodella Luca, de Manzoni Giovanni
Prima Divisione Clinicizzata di Chirurgia Generale, Universitá di Verona, Verona, Italy.
J Surg Oncol. 2005 Sep 15;91(4):226-31. doi: 10.1002/jso.20302.
Preoperative assessment of gastro-esophageal junction (GEJ) adenocarcinoma stage and its location according to Siewert are essential for planning the therapeutic approach. The present study was aimed at analyzing the utility of endoscopic ultrasonography (EUS) in evaluating GEJ adenocarcinoma stage and whether this modality added to EGD improves assessment of Siewert type.
The results of 51 patients studied by EGD plus EUS (EGD/EUS group) were compared with the results of 54 patients studied by EGD only (EGD group).
A differentiation of pT1 tumors was attempted by measurement of the tumor length using 4 cm as a criterion. This goal was not achieved because of a high rate of advanced tumors less than 4 cm (sensitivity and specificity were 81.3% and 34.2%, respectively). Conversely EUS ability in pT1 assessment was very reliable (92%). The accuracy in defining the Siewert type was 72.5% and 64.8% for EGD/EUS and EGD groups, respectively (P = 0.394). Some difficulties in distinguishing between type II and III tumors were observed in both groups with an extremely low specificity (44%) in classifying type II tumors by EGD group.
EUS seems to be essential in differentiating pT1 from advanced tumors. It shows an accuracy in defining the Siewert type of 72.5%, with some difficulties in distinguishing from type II and III tumors.
术前评估胃食管交界(GEJ)腺癌的分期及其根据Siewert分型确定的位置对于规划治疗方案至关重要。本研究旨在分析内镜超声检查(EUS)在评估GEJ腺癌分期中的效用,以及这种检查方式联合上消化道内镜检查(EGD)是否能改善对Siewert分型的评估。
将51例接受EGD联合EUS检查(EGD/EUS组)的患者结果与54例仅接受EGD检查(EGD组)的患者结果进行比较。
尝试以4 cm为标准通过测量肿瘤长度来鉴别pT1期肿瘤。由于小于4 cm的进展期肿瘤发生率较高,该目标未达成(敏感性和特异性分别为81.3%和34.2%)。相反,EUS在pT1期评估中的能力非常可靠(92%)。EGD/EUS组和EGD组在确定Siewert分型方面的准确率分别为72.5%和64.8%(P = 0.394)。两组在鉴别II型和III型肿瘤时均存在一些困难,EGD组对II型肿瘤分类的特异性极低(44%)。
EUS似乎对于区分pT1期肿瘤和进展期肿瘤至关重要。它在确定Siewert分型方面的准确率为72.5%,在鉴别II型和III型肿瘤时存在一些困难。